期刊文献+

IL1RN和IGLV基因与多形性胶质母细胞瘤放疗关系的研究 被引量:2

Expression profile of glioblastoma tissue before and after radiotherapy and Its Significance
原文传递
导出
摘要 目的多形性胶质母细胞瘤(GBM)组织放射治疗前后基因表达谱中相关基因表达差异的变化及意义。方法采用BioStarH-141s含13929条人类全长基因cDNA表达谱芯片,对5例胶质母细胞瘤组织进行放疗前及放疗60Gy后检测,并分析它们之间免疫相关基因表达差异。结果多形性胶质母细胞瘤放疗60Gy后与放疗前比较,表达差异基因中改变最明显的功能群是免疫系统相关的基因,IL1RN和IGLV上调。细胞增殖、细胞调亡、细胞周期、DNA修复系统也有部分基因发生明显变化。结论提示对胶质母细胞瘤组织照射60Gy后基因表达谱改变的研究可以更好地阐明放射敏感性差异机理,为放疗前或放疗早期寻找到预测放射敏感性分子标志提供理论依据。 Objective To study the change of gene express profile of glioblastoma(GBM) tissue before-and-after the radiation and analyze the correlation among the gene.Methods BioStarH-141s profile genechip which contained 13929 points of full length human genes was used to detect five GBM tissue before-and-after radiation and to analyse the genes expressed differently.Results The results showed that,after radiation of 60Gy,there were 18 genes expressed differently,including 8 up-regulate genes and 10 down-regulate genes.And the gene group which changed the most obviously was related to the function of immunity,for instance,up-regulate genes: IL1RN and IGLV.Some genes related to cell proliferation、apoptosis、cell cycle and DNA-repair system,also differently expressed in evidence.Conclusions The results indicated that,research the change of the gene express profile of GBM tissue before and after the radiation could better clarify the mechanism of radiation sensitivity.It may afford theoretic idea to find molecular markers to predict radiation sensitivity before or at the forepart of radiation therapy.
出处 《医药论坛杂志》 2012年第6期1-2,5,共3页 Journal of Medical Forum
基金 国家高技术研究发展计划(863计划)项目(2005AA001070)
关键词 多形性胶质母细胞瘤 放射治疗 基因表达谱 Glioblastoma; Radiotherapy; Gene expression; Genechip
  • 相关文献

参考文献8

  • 1Schwartzbaum JA, Fisher JL, AldapeKD, et al. Epidemiology and molecular pathology of glioma [ J ]. Nat cli prac, 2006,2 ( 9 ) : 494 -503. 被引量:1
  • 2Taggart CC, Greene CM, McEovaney NG,et al. Secretory leucop-rotease inhibitor prevents lipopolysaccharide - inducde IkappaB alpha degradation without affecting phosphorylation or ubiquitina- tion [ J ]. J Biol Chem,2002,277 ( 37 ) : 33648-33653. 被引量:1
  • 3Bohman LE, Swanson KR, Moore JL, et al. Magnetic resonance imaging characteristics of glioblastoma muhiforme: implications for understanding glioma ontogeny [ J ]. Neurosurgery, 2010,67 (5) :1319-1327. 被引量:1
  • 4Meldolesi J, Chieregatti E. Fusion has found its calcium sensor [ J]. Nat Cell Biol,2004,6(6) :476-478. 被引量:1
  • 5Lacal JC. How molecular biology can improve clinical manage- ment: the MammaPrint experience [ J]. Clin Transl 0ncol,2007, 9(4) : 203. 被引量:1
  • 6曹锐峰,章翔,陈伟,江新标,姬西团,王西玲.星形胶质瘤细胞摄取BPA的时间及细胞周期相关性研究[J].解放军医学杂志,2004,29(2):150-152. 被引量:1
  • 7De vos FY, Middelburg TA, Seynaeve C, et al. Ecthyma gangre- nosum caused by Pseudomonas aeruginosa in a patient with astro- cytoma treated with chemotherapy [ J]. J Infect C hemother,2010, 16(1) :59-61. 被引量:1
  • 8周开宇,王广涛,罗永康,金杭煌,毛天明.恶性胶质瘤术后放疗同步化疗疗效初步分析[J].中华肿瘤防治杂志,2010,17(1):70-72. 被引量:9

二级参考文献11

  • 1葛立本,赵凯军,陶育纯.全脑照射加Vm-26治疗肺癌脑转移临床研究[J].肿瘤防治杂志,2005,12(15):1168-1169. 被引量:4
  • 2Montemor J P, Peria F M, Monti C R, et al. Concurrent chemoradiotherapy with weekly paclitaxel in malignant cerebral glioma treatment[J]. Onkologie, 2008,31(8- 9) : 435-439. 被引量:1
  • 3La Rocca R V, Mehdorn H M. Localized BCNU chemotherapy and the multimodal management of malignant glioma[J]. Curr Med Res Opin, 2009, 25(1):149-160. 被引量:1
  • 4Donato V, Papaleo A, Castrichino A, et al. Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide[J].Tumori, 2007, 93(3) :248-256. 被引量:1
  • 5Prabhakara S, Kalia V K. Optimizing radiotherapy of brain turnouts by a combination of temozolomide & lonidamine[J]. Indian J Med Res, 2008, 128(2) :140-148. 被引量:1
  • 6Mane J M, Fernandez R, Munoz A, et al. Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme[J]. Tumori, 2004, 90(6): 562-566. 被引量:1
  • 7Glas M, Hundsberger T, Stuplich M, et al. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma[J]. Oncology, 2009, 76(3):184-189. 被引量:1
  • 8Brandes A A, Turazzi S, Basso U, et al. A multidrug combination designed for reversing resistance to BCNU in glioblastoma multiforme[J]. Neurology, 2002, 58(12) : 1759-1764. 被引量:1
  • 9Hegi M E, Diserens A C, Godard S, etal. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide[J]. Clin Cancer Res, 2004, 10 (6) : 1871- 1874. 被引量:1
  • 10Kocher M, Kunze S, Eich H T, et al. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma[J]. Strahlenther Onkol, 2005, 181(3) :157-163. 被引量:1

共引文献8

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部